IBDEI1XM ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32770,0)
 ;;=Z02.1^^128^1635^10
 ;;^UTILITY(U,$J,358.3,32770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32770,1,3,0)
 ;;=3^Pre-Employment Examination
 ;;^UTILITY(U,$J,358.3,32770,1,4,0)
 ;;=4^Z02.1
 ;;^UTILITY(U,$J,358.3,32770,2)
 ;;=^5062634
 ;;^UTILITY(U,$J,358.3,32771,0)
 ;;=Z02.3^^128^1635^11
 ;;^UTILITY(U,$J,358.3,32771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32771,1,3,0)
 ;;=3^Recruitment to Armed Forces Examination
 ;;^UTILITY(U,$J,358.3,32771,1,4,0)
 ;;=4^Z02.3
 ;;^UTILITY(U,$J,358.3,32771,2)
 ;;=^5062636
 ;;^UTILITY(U,$J,358.3,32772,0)
 ;;=Z00.5^^128^1635^9
 ;;^UTILITY(U,$J,358.3,32772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32772,1,3,0)
 ;;=3^Potential Organ/Tissue Donor Examination
 ;;^UTILITY(U,$J,358.3,32772,1,4,0)
 ;;=4^Z00.5
 ;;^UTILITY(U,$J,358.3,32772,2)
 ;;=^5062607
 ;;^UTILITY(U,$J,358.3,32773,0)
 ;;=Z01.419^^128^1635^8
 ;;^UTILITY(U,$J,358.3,32773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32773,1,3,0)
 ;;=3^Gyn Exam w/ Normal Findings
 ;;^UTILITY(U,$J,358.3,32773,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,32773,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,32774,0)
 ;;=Z01.411^^128^1635^7
 ;;^UTILITY(U,$J,358.3,32774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32774,1,3,0)
 ;;=3^Gyn Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,32774,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,32774,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,32775,0)
 ;;=Z00.01^^128^1635^5
 ;;^UTILITY(U,$J,358.3,32775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32775,1,3,0)
 ;;=3^General Medical Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,32775,1,4,0)
 ;;=4^Z00.01
 ;;^UTILITY(U,$J,358.3,32775,2)
 ;;=^5062600
 ;;^UTILITY(U,$J,358.3,32776,0)
 ;;=Z02.0^^128^1635^2
 ;;^UTILITY(U,$J,358.3,32776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32776,1,3,0)
 ;;=3^Exam for Admission to Educational Institution
 ;;^UTILITY(U,$J,358.3,32776,1,4,0)
 ;;=4^Z02.0
 ;;^UTILITY(U,$J,358.3,32776,2)
 ;;=^5062633
 ;;^UTILITY(U,$J,358.3,32777,0)
 ;;=Z02.2^^128^1635^3
 ;;^UTILITY(U,$J,358.3,32777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32777,1,3,0)
 ;;=3^Exam for Admission to Residential Institution
 ;;^UTILITY(U,$J,358.3,32777,1,4,0)
 ;;=4^Z02.2
 ;;^UTILITY(U,$J,358.3,32777,2)
 ;;=^5062635
 ;;^UTILITY(U,$J,358.3,32778,0)
 ;;=Z85.43^^128^1636^51
 ;;^UTILITY(U,$J,358.3,32778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32778,1,3,0)
 ;;=3^Personal Hx of Malig Neop Ovary
 ;;^UTILITY(U,$J,358.3,32778,1,4,0)
 ;;=4^Z85.43
 ;;^UTILITY(U,$J,358.3,32778,2)
 ;;=^5063420
 ;;^UTILITY(U,$J,358.3,32779,0)
 ;;=Z85.46^^128^1636^52
 ;;^UTILITY(U,$J,358.3,32779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32779,1,3,0)
 ;;=3^Personal Hx of Malig Neop Prostate
 ;;^UTILITY(U,$J,358.3,32779,1,4,0)
 ;;=4^Z85.46
 ;;^UTILITY(U,$J,358.3,32779,2)
 ;;=^5063423
 ;;^UTILITY(U,$J,358.3,32780,0)
 ;;=Z85.6^^128^1636^49
 ;;^UTILITY(U,$J,358.3,32780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32780,1,3,0)
 ;;=3^Personal Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,32780,1,4,0)
 ;;=4^Z85.6
 ;;^UTILITY(U,$J,358.3,32780,2)
 ;;=^5063434
 ;;^UTILITY(U,$J,358.3,32781,0)
 ;;=Z85.71^^128^1636^47
 ;;^UTILITY(U,$J,358.3,32781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32781,1,3,0)
 ;;=3^Personal Hx of Hodgkin Lymphoma
 ;;^UTILITY(U,$J,358.3,32781,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,32781,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,32782,0)
 ;;=Z85.820^^128^1636^50
 ;;^UTILITY(U,$J,358.3,32782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32782,1,3,0)
 ;;=3^Personal Hx of Malig Melanoma of SKin
 ;;^UTILITY(U,$J,358.3,32782,1,4,0)
 ;;=4^Z85.820
